Compare CDNA & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | RAMP |
|---|---|---|
| Founded | 1998 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2007 | 1994 |
| Metric | CDNA | RAMP |
|---|---|---|
| Price | $53.96 | $37.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $28.00 | ★ $35.60 |
| AVG Volume (30 Days) | ★ 1.0M | 997.2K |
| Earning Date | 04-28-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22500.00 |
| EPS | ★ 2.13 | 0.28 |
| Revenue | $48,324,000.00 | ★ $812,940,000.00 |
| Revenue This Year | $16.01 | $11.18 |
| Revenue Next Year | $11.31 | $9.09 |
| P/E Ratio | ★ $25.48 | $135.32 |
| Revenue Growth | ★ 18.93 | 9.03 |
| 52 Week Low | $13.95 | $21.71 |
| 52 Week High | $55.16 | $38.23 |
| Indicator | CDNA | RAMP |
|---|---|---|
| Relative Strength Index (RSI) | 69.87 | 49.82 |
| Support Level | $45.74 | $37.65 |
| Resistance Level | N/A | $37.91 |
| Average True Range (ATR) | 2.17 | 0.14 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 85.84 | 35.23 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
LiveRamp Holdings Inc is a technology company that empowers marketers and media owners to deliver and measure marketing performance everywhere it matters. Its data collaboration network seamlessly unites data across advertisers, ad tech platforms, publishers, data providers, and commerce media networks, unlocking insights that deliver transformational consumer experiences and drive measurable business outcomes. The group's platform is engineered for AI agent accessibility, facilitating autonomous data collaboration between the specialized AI agents utilized by customers and partners and the networked platform. It generates the geographic revenue from the United States, followed by Europe, Asia-Pacific ("APAC"), and Other.